ask="0.98"
ask_size="100"
average_daily_volume="115772"
bid="0.75"
bid_size="4000"
book_value="0.53"
change="+0.02"
change_from_200_day_moving_average="-0.46"
change_from_50_day_moving_average="-0.24"
change_from_52_week_high="-2.23"
change_From_52_week_low="0.09"
change_in_percent="+2.26%"
close="0.90"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.01"
ebitda="-13.93M"
eps_estimate_current_year="-0.82"
eps_estimate_next_quarter="-0.22"
eps_estimate_next_year="-0.73"
ex_dividend_date="N/A"
float_shares="6119000"
high="0.92"
high_52_weeks="3.13"
last_trade_date="3/17/2017"
last_trade_price="0.90"
last_trade_size="100"
last_trade_time="3:58pm"
low="0.87"
low_52_weeks="0.81"
market_capitalization="14.75M"
moving_average_200_day="1.36"
moving_average_50_day="1.14"
name="Bioblast Pharma Ltd. - Ordinary"
notes="N/A"
one_year_target_price="9.00"
open="0.88"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-33.85%"
percent_change_from_50_day_moving_average="-20.84%"
percent_change_from_52_week_high="-71.25%"
percent_change_from_52_week_low="+11.11%"
previous_close="0.88"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.66"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16391000"
short_ratio="1.63"
stock_exchange="NGM"
symbol="ORPN"
volume="26593"
weeks_range_52="0.81 - 3.13"
